BioSpace News Archive

It was a moderately busy week for clinical trial news. Here’s a look.

In a 56-page response to the investigation from the U.S. Food and Drug Administration, Novartis said the Kaspar brothers personally manipulated or instructed others to alter some of the preclinical data that ultimately led to the approval of the $2.1 million priced SMA therapy.

Learn about the top resume buzzwords you need to include in your resume. Includes tips for branding yourself, positioning yourself as a leader, and more!

PDS Biotechnology Corporation announced that it has reviewed limited available patient clinical outcome data from its previously reported Phase 1 study.

Hutchison China MediTech Limited (“Chi-Med”) shares additional analyses from three completed and ongoing clinical studies of fruquintinib and savolitinib at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (“CSCO”) on September 18 to 22, 2019 in Xiamen, China.

Company’s insulin-based Imotope™ IMCY-0098 shows excellent safety profile and promising clinical trends

The Janssen Pharmaceutical Companies of Johnson & Johnson announced multiple data presentations from its solid tumour portfolio, including key prostate cancer data, will be featured at the European Society for Medical Oncology 2019 Annual Congress, taking place 27th September to 1st October in Barcelona, Spain.

The Clinical Research Association of Canada has launched and is now offering the only Canadian clinical research designation.

Dornier MedTech Launches New Image Post-Processing Software for Urology to Improve Kidney Stone Treatment Outcomes

Biom’up SA announced that Patrice Ferrand was appointed CEO, replacing Dr. Jan Ohrstrom. Dr. Ohrstrom, who was appointed CEO in May of this year, remains Chairman of the Board, a role in which he has served for the Company since 2015.